ad5.f35-hgcc-padre
Vaccineexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04111172)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Membrane cofactor proteinImmunity, active
immunity, active - cd46
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04111172 | Phase 2 | Dec 31, 2019 | Thomas Jefferson University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thomas Jefferson University | Academic/Hospital | 1 | 1 | 1 | 2019 |
1 organizations
Page 1 / 1